Literature DB >> 9741351

Wild isolates of murine cytomegalovirus induce myocarditis and antibodies that cross-react with virus and cardiac myosin.

D Fairweather1, C M Lawson, A J Chapman, C M Brown, T W Booth, J M Papadimitriou, G R Shellam.   

Abstract

The laboratory-adapted K181 strain of murine cytomegalovirus (MCMV) induces both acute and chronic myocarditis, associated with autoantibodies to cardiac myosin, in susceptible BALB/c mice. However, the K181 MCMV strain has been maintained in the laboratory for many years and may not resemble naturally occurring strains of MCMV in its ability to induce myocarditis. Accordingly, six different isolates of MCMV from wild Mus domesticus were compared with K181 MCMV for their ability to induce myocarditis and autoantibodies to cardiac myosin in BALB/c mice. These isolates were shown to induce acute myocarditis similar to K181 MCMV, with associated focal and diffuse myocardial inflammation. However, the levels of myocarditis induced by the wild isolates during the chronic phase of the disease (days 32-56 post-infection) were low in contrast to the K181 strain. Interestingly, 30% of wild-trapped mice showed histological evidence of myocarditis and all were sero-positive to MCMV. Sera from BALB/c mice infected with wild MCMV isolates and from wild-trapped mice contained antibodies that cross-reacted with MCMV and cardiac myosin (S2 region). The cross-reactive region of MCMV was found to be a 50,000-55,000 MW viral polypeptide. These findings suggest that molecular mimicry may be involved in the pathogenesis of autoimmune myocarditis following infection with both laboratory and wild MCMV strains.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9741351      PMCID: PMC1364215          DOI: 10.1046/j.1365-2567.1998.00500.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  36 in total

1.  Delayed-type hypersensitivity responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.

Authors:  C M Lawson; J E Grundy; G R Shellam
Journal:  J Gen Virol       Date:  1987-09       Impact factor: 3.891

Review 2.  Autoimmunity in myocarditis: relevance of animal models.

Authors:  S A Huber
Journal:  Clin Immunol Immunopathol       Date:  1997-05

3.  Genetic control of mouse cytomegalovirus-induced myocarditis.

Authors:  C M Lawson; H O'Donoghue; W N Bartholomaeus; W D Reed
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

4.  Characterization of neutralizing monoclonal antibodies to murine cytomegalovirus.

Authors:  H E Farrell; G R Shellam
Journal:  J Gen Virol       Date:  1990-03       Impact factor: 3.891

5.  Multiple autoantibodies following cytomegalovirus infection: virus distribution and specificity of autoantibodies.

Authors:  W N Bartholomaeus; H O'Donoghue; D Foti; C M Lawson; G R Shellam; W D Reed
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

6.  Antibody responses to murine cytomegalovirus in genetically resistant and susceptible strains of mice.

Authors:  C M Lawson; J E Grundy; G R Shellam
Journal:  J Gen Virol       Date:  1988-08       Impact factor: 3.891

7.  The role of T cells in mouse cytomegalovirus myocarditis.

Authors:  C M Lawson; H O'Donoghue; W D Reed
Journal:  Immunology       Date:  1989-05       Impact factor: 7.397

8.  Immunoblot analysis of the antibody response to murine cytomegalovirus in genetically resistant and susceptible mice.

Authors:  H E Farrell; G R Shellam
Journal:  J Gen Virol       Date:  1989-10       Impact factor: 3.891

9.  Identification of a particular antigen from a parasite cDNA library using antibodies affinity purified from selected portions of Western blots.

Authors:  J A Beall; G F Mitchell
Journal:  J Immunol Methods       Date:  1986-02-12       Impact factor: 2.303

10.  Analysis of structural polypeptides of purified human cytomegalovirus.

Authors:  K S Kim; V J Sapienza; R I Carp; H M Moon
Journal:  J Virol       Date:  1976-12       Impact factor: 5.103

View more
  14 in total

1.  Cardiomyopathy is linked to complement activation.

Authors:  Marina Afanasyeva; Noel R Rose
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

2.  Human cytomegalovirus pp65 lower matrix protein: a humoral immunogen for systemic lupus erythematosus patients and autoantibody accelerator for NZB/W F1 mice.

Authors:  M Chang; M-R Pan; D-Y Chen; J-L Lan
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

3.  Ganciclovir and cidofovir treatment of cytomegalovirus-induced myocarditis in mice.

Authors:  J C Lenzo; G R Shellam; C M Lawson
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

4.  Calpain inhibition protects against virus-induced apoptotic myocardial injury.

Authors:  R L DeBiasi; C L Edelstein; B Sherry; K L Tyler
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

Review 5.  Unresolved issues in theories of autoimmune disease using myocarditis as a framework.

Authors:  Robert Root-Bernstein; DeLisa Fairweather
Journal:  J Theor Biol       Date:  2014-12-04       Impact factor: 2.691

6.  Retention of anergy and inhibition of antibody responses during acute γ herpesvirus 68 infection.

Authors:  Andrew Getahun; Mia J Smith; Igor Kogut; Linda F van Dyk; John C Cambier
Journal:  J Immunol       Date:  2012-08-17       Impact factor: 5.422

7.  Type I interferon gene therapy protects against cytomegalovirus-induced myocarditis.

Authors:  Vanessa S Cull; Emmalene J Bartlett; Cassandra M James
Journal:  Immunology       Date:  2002-07       Impact factor: 7.397

8.  The specificity of cross-reactivity: promiscuous antibody binding involves specific hydrogen bonds rather than nonspecific hydrophobic stickiness.

Authors:  Leo C James; Dan S Tawfik
Journal:  Protein Sci       Date:  2003-10       Impact factor: 6.725

9.  Laboratory strains of murine cytomegalovirus are genetically similar to but phenotypically distinct from wild strains of virus.

Authors:  L M Smith; A R McWhorter; L L Masters; G R Shellam; A J Redwood
Journal:  J Virol       Date:  2008-04-16       Impact factor: 5.103

10.  Slam haplotype 2 promotes NKT but suppresses Vγ4+ T-cell activation in coxsackievirus B3 infection leading to increased liver damage but reduced myocarditis.

Authors:  Sally Ann Huber; Brian Roberts; Mohamad Moussawi; Jonathan E Boyson
Journal:  Am J Pathol       Date:  2012-11-27       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.